Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an...

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer, frequently driven by KRAS mutations.
• p21-activated kinases (PAKs), particularly PAK4, are implicated in PDA tumorigenesis and immune evasion.
• PAK4 inhibition enhances cytotoxic T cell infiltration, but the underlying mechanisms require elucidation.

Purpose of the Study:

• To investigate the impact of PAK4 inhibition on major histocompatibility complex class I (MHC I) expression in PDA cells.
• To determine the role of autophagy in mediating the effects of PAK4 inhibition on MHC I expression and immune response.
• To elucidate the molecular mechanisms by which PAK4 influences PDA immune evasion.

Main Methods:

• Utilized proteomic analysis, fluorescence-activated cell sorting (FACS), and immunoblotting.
• Examined the effects of PAK4 knockout (KO) in human PDA cell lines (MiaPaCa-2 and PANC-1).
• Assessed MHC I expression and autophagy levels, including experiments with autophagy inhibition using chloroquine (CQ).

Main Results:

• PAK4 KO significantly increased MHC I expression in both MiaPaCa-2 and PANC-1 cell lines.
• PAK4 KO also enhanced cancer cell autophagy; however, autophagy inhibition did not affect apoptosis or cell death.
• Crucially, inhibiting autophagy with CQ did not alter the increased MHC I expression induced by PAK4 KO, indicating an autophagy-independent mechanism.

Conclusions:

• PAK4 plays a significant role in regulating MHC I expression in pancreatic ductal adenocarcinoma cells.
• The observed increase in MHC I expression following PAK4 inhibition is independent of autophagy.
• These findings suggest novel therapeutic strategies targeting PAK4 to enhance anti-tumor immunity in PDA.